Page last updated: 2024-10-24

carbamazepine epoxide and Acute Disease

carbamazepine epoxide has been researched along with Acute Disease in 1 studies

carbamazepine epoxide: metabolite of carbamazepine; RN given refers to unlabeled cpd
carbamazepine-10,11-epoxide : An epoxide and metabolite of carbamazepine.

Acute Disease: Disease having a short and relatively severe course.

Research Excerpts

ExcerptRelevanceReference
" During the first week, the dosage was rapidly increased to 800 mg/day in order to produce steady-state plasma levels of carbamazepine on Day 7."1.28Carbamazepine and its 10,11-epoxide metabolite in acute mania: clinical and pharmacokinetic correlates. ( Alric, R; Blayac, JP; Cociglio, M; Hue, B; Lonjon, R; Petit, P; Pouget, R; Sluzewska, A, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Petit, P1
Lonjon, R1
Cociglio, M1
Sluzewska, A1
Blayac, JP1
Hue, B1
Alric, R1
Pouget, R1

Other Studies

1 other study available for carbamazepine epoxide and Acute Disease

ArticleYear
Carbamazepine and its 10,11-epoxide metabolite in acute mania: clinical and pharmacokinetic correlates.
    European journal of clinical pharmacology, 1991, Volume: 41, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Female; Humans; Male; Middl

1991